Brief summary of the agreement
Anyone is free:
· to copy, distribute, and display the work;
· to make derivative works;
· to make commercial use of the work;
Under the following conditions: Attribution
· the original author must be given credit;
· for any reuse or distribution, it must be made clear to others what the license terms of this work are;
· any of these conditions can be waived if the authors gives permission.
Statutory fair use and other rights are in no way affected by the above
Author Biographies
Kloub Hanane
Department of Medical Oncology, National Institute of Oncology, Rabat, Morocco
Benhmida Salma
Department of Medical Oncology, National Institute of Oncology, Rabat, Morocco
Bellahammou Khadija
Department of Medical Oncology, National Institute of Oncology, Rabat, Morocco
Elghissassi Ibrahim
Department of Medical Oncology, National Institute of Oncology, Rabat, Morocco
Boutayeb Saber
Department of Medical Oncology, National Institute of Oncology, Rabat, Morocco
M’rabti Hind
Department of Medical Oncology, National Institute of Oncology, Rabat, Morocco
Errihani Hassan
Department of Medical Oncology, National Institute of Oncology, Rabat, Morocco
Main Article Content
Peritoneal carcinomatosis, an unusual and only site of metastasis from lung adenocarcinoma
Kloub Hanane
Benhmida Salma
Bellahammou Khadija
Elghissassi Ibrahim
Boutayeb Saber
M’rabti Hind
Errihani Hassan
Abstract
Isolated peritoneal metastases of lung adenocarcinoma are very rare, even exceptional, occurring most often in the context of a multi-metastatic disease. This report presents a rare clinical case of isolated peritoneal metastasis from lung adenocarcinoma. We report a 56-year-old male who was monitored for lung adenocarcinoma whose evolution has been marked by an isolated metastatic recurrence in the peritoneum objectified by an abdominal-pelvic computed tomography (CT) and confirmed by a laparoscopy with abiopsy of the peritoneal nodules. The patient had received palliative chemotherapy with gemcitabine, cisplatin and bevacizumab. The evolution was marked by a progressive deterioration of the general condition and death two months after the third treatment cycle. Peritoneal carcinomatosis from lung adenocarcinoma is a very rare event, and is often associated with a poor prognosis.
Pan African Medical Journal 2016; 23
Donate
AJOL is a Non Profit Organisation that cannot function without donations.
AJOL and the millions of African and international researchers who rely on our free services are deeply grateful for your contribution.
AJOL is annually audited and was also independently assessed in 2019 by E&Y.
Your donation is guaranteed to directly contribute to Africans sharing their research output with a global readership.
Once off donations here:
For annual AJOL Supporter contributions, please view our Supporters page.
Tell us what you think and showcase the impact of your research!
Please take 5 minutes to contribute to our survey so that we can better understand the contribution that African research makes to global and African development challenges. Share your feedback to help us make sure that AJOL's services support and amplify the voices of researchers like you.